Cleveland Clinic-Led Trial Finds Testosterone-Replacement Therapy Does Not Increase Incidence of Major Adverse Cardiac Events for Men With Low Testosterone
June 17, 2023
June 17, 2023
CLEVELAND, Ohio, June 17 (TNSjou) -- The Cleveland Clinic issued the following news release:
A Cleveland Clinic-led trial found that testosterone-replacement therapy did not result in a higher incidence of major adverse cardiac events in middle-aged and older men with hypogonadism (also known as low testosterone) who also had preexisting or a high risk of cardiovascular disease. However, researchers still urge caution when considering testosterone therapy.
Results from . . .
A Cleveland Clinic-led trial found that testosterone-replacement therapy did not result in a higher incidence of major adverse cardiac events in middle-aged and older men with hypogonadism (also known as low testosterone) who also had preexisting or a high risk of cardiovascular disease. However, researchers still urge caution when considering testosterone therapy.
Results from . . .